Towards Noninvasive DBS of the Basal Ganglia in Parkinson's Disease Using TUS
Trial
N/A
Active, not recruiting
Sept. 14, 2025
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
Trial
Phase 2
Completed
Sept. 14, 2025
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment
Trial
Phase 2
Completed
Sept. 11, 2025
Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease
Trial
Phase 1
Completed
Sept. 11, 2025
A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease
Trial
Phase 1
Recruiting
Sept. 11, 2025
Bilateral Putaminal Convection of Adeno-Associated Virus Vector Serotype 2 Glial Cell Line-Derived Neurotrophic Factor Gene Therapy in Parkinson's Disease May Provide Glial Cell Line-Derived Neurotrophic Factor Transgene Expression to Caudate Nucleus: Potential Role of Perivascular and Other Low Resistance Leakage Pathways.
Research
Neurosurgery
Sept. 11, 2025
The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease
Trial
Phase 1
Recruiting
Sept. 10, 2025
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Trial
Phase 2
Recruiting
Sept. 9, 2025
The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease
Trial
N/A
Active, not recruiting
Sept. 9, 2025
Parkinson's Disease Progression Study
Trial
N/A
Active, not recruiting
Sept. 8, 2025
Comparing Antipsychotic Medications in LBD Over Time
Trial
Phase 4
Recruiting
Sept. 8, 2025
Prolactin, Inflammation, and Parkinson's Severity
Trial
N/A
Enrolling by invitation
Sept. 8, 2025
Gait Re-education Program in Subjects With Parkinson´s Disease
Trial
N/A
Completed
Sept. 8, 2025
DBS of the MLR for Gait and Balance Disorders in PD Patients
Trial
N/A
Completed
Sept. 7, 2025
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
Trial
Phase 1
Recruiting
Sept. 4, 2025
A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants
Trial
Phase 1
Completed
Sept. 4, 2025
The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
Trial
Phase 2
Recruiting
Sept. 4, 2025
Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease
Trial
N/A
Completed
Sept. 4, 2025
Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study
Trial
N/A
Completed
Sept. 3, 2025
Microbiota Intervention to Change the Response of Parkinson's Disease
Trial
Phase 1
Suspended
Sept. 3, 2025